First came reports about reduced food cravings. Then alcohol. Then smoking. Now the pattern is extending to an even more surprising area: gambling.
Online communities are filling with stories of people who were regular casino-goers or sports bettors finding they've completely lost interestâwithout trying to quit.
The Stories Are Striking
The Dopamine Connection
Gambling, like eating and substance use, is fundamentally about dopamineâthe brain's reward and motivation neurotransmitter.
The unpredictability of gambling creates powerful dopamine spikes. A "near miss" on a slot machine actually releases MORE dopamine than a small winâtraining the brain to keep chasing.
GLP-1 receptors are found throughout the brain's reward circuitry, including the nucleus accumbens and ventral tegmental area. By modulating dopamine release in these regions, GLP-1 medications may dampen the reward signal from ALL compulsive behaviorsânot just eating.
What Researchers Think
Addiction researchers are cautiously excited. The theory is that GLP-1 medications act as a "volume knob" for reward sensitivity across the board.
Dr. Kyle Simmons, a researcher studying GLP-1s and addiction, has noted that the drugs appear to reduce the intensity of wanting without affecting likingâyou might still enjoy a nice meal, but you're not obsessively thinking about food all day.
The same may apply to gambling: you can still have fun at a casino, but the compulsive need to gamble fades.
Not Yet Proven
Researchers are taking notice, though. The sheer volume of consistent reports suggests something real is happening, and formal studies are being designed.
Beyond Gambling: All Compulsive Behaviors?
The gambling reports fit a broader pattern. People are reporting reduced urges related to:
- Compulsive shopping
- Nail biting
- Skin picking
- Phone/social media scrolling
- Porn consumption
All of these behaviors share a common thread: dopamine-driven reward seeking. If GLP-1s truly modulate this system globally, the implications for behavioral medicine are enormous.
- Patient testimonials from online GLP-1 communities.
- Research on GLP-1 receptor distribution in brain reward centers.
- Dr. Kyle Simmons research on GLP-1s and addiction.
- Mechanistic studies on dopamine modulation by GLP-1 receptor agonists.
Ready to Get Started?
Compare verified GLP-1 providers. All include telehealth consultation + medication.
Affiliate Disclosure: We may earn a commission at no extra cost to you.